Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-09

Clinical Trial Update: A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

This clinical trial update presents the results of a Phase III study of abatacept in Japanese subjects with rheumatoid arthritis, with results posted in August …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-08-09